Endocrinology & Diabetes

Pathophysiology of Diabetes & Metabolic Syndrome

The pathophysiology of diabetes and metabolic syndrome is rooted in a complex interplay of metabolic, hormonal, and inflammatory disturbances. This track offers a deep exploration of insulin resistance mechanisms, beta-cell stress responses, glucotoxicity, lipotoxicity, and the molecular drivers that disrupt normal energy homeostasis. Presentations will examine how adipose tissue dysfunction, altered incretin signaling, gut microbiome imbalance, and chronic low-grade inflammation converge to initiate metabolic deterioration. Speakers will also evaluate newly discovered pathways such as adipokine–cytokine interactions, hepatic insulin signaling regulators, and genetic susceptibilities that contribute to disease variability.

In the second part of this track, attendees will learn how these mechanisms translate into clinical phenotypes, differential progression rates, and individualized treatment needs. Emphasis will be placed on identifying early biological signatures, pathway-specific therapeutic targets, and systems-level models explaining disease heterogeneity. Through a combination of molecular insights and clinical correlations, participants will gain a more precise understanding of how metabolic syndrome evolves into overt diabetes—and how early biological disruptions can be reversed or attenuated through optimized intervention strategies.